BACKGROUND & OBJECTIVES: The polymeric immunoglobulin receptor (pIgR) is produced by mucosal epithelial cells and plays a crucial role in mucosal immunity. At the basolateral surface of mucosal cells, the pIgR binds predominantly polymeric immunoglobulins, such as dimeric IgA and polymeric IgA (pIgA) and mediates their transport across the polarized cells. This results in apical release of secretory component (SC), either free or bound covalently to IgA, forming secretory IgA (SIgA). The choline-binding protein (Cbp) SpsA, also called PspC and CbpA, has been shown to interact with the pIgR. A hexapeptide motif in SpsA was identified as the minimal binding motif required for binding specifically to pIgR and SC. The present study was carried out to show that the hexapeptide motif in SpsA is crucial for the interaction of pneumococci and pIgR-expressing cells. METHODS: Streptococcus pneumoniae were cultured to mid-log phase. Calu-3 cells and MDCK epithelial cells, stably transfected with the hpIgR cDNA in pCB6 were used in in vitro infection experiments. Pneumococcal adherence to and invasion of epithelial cells were assayed. RESULTS: By the use of the N-terminal domain of SpsA and SpsA(201), which exhibits a single amino acid substitution in the pIgR-binding motif, in vitro assays indicated the association of the identified hexapeptide motif, located between amino acid 198 and 203 in SpsA, with pneumococcal adherence to and invasion of hpIgR-expressing cells. INTERPRETATION & CONCLUSION: The present findings demonstrated not only the crucial role of the hexapeptide of SpsA, not only for the SpsA-pIgR interaction, but also for adherence and invasion of hpIgR-expressing cells.
BACKGROUND & OBJECTIVES: The polymeric immunoglobulin receptor (pIgR) is produced by mucosal epithelial cells and plays a crucial role in mucosal immunity. At the basolateral surface of mucosal cells, the pIgR binds predominantly polymeric immunoglobulins, such as dimeric IgA and polymeric IgA (pIgA) and mediates their transport across the polarized cells. This results in apical release of secretory component (SC), either free or bound covalently to IgA, forming secretory IgA (SIgA). The choline-binding protein (Cbp) SpsA, also called PspC and CbpA, has been shown to interact with the pIgR. A hexapeptide motif in SpsA was identified as the minimal binding motif required for binding specifically to pIgR and SC. The present study was carried out to show that the hexapeptide motif in SpsA is crucial for the interaction of pneumococci and pIgR-expressing cells. METHODS:Streptococcus pneumoniae were cultured to mid-log phase. Calu-3 cells and MDCK epithelial cells, stably transfected with the hpIgR cDNA in pCB6 were used in in vitro infection experiments. Pneumococcal adherence to and invasion of epithelial cells were assayed. RESULTS: By the use of the N-terminal domain of SpsA and SpsA(201), which exhibits a single amino acid substitution in the pIgR-binding motif, in vitro assays indicated the association of the identified hexapeptide motif, located between amino acid 198 and 203 in SpsA, with pneumococcal adherence to and invasion of hpIgR-expressing cells. INTERPRETATION & CONCLUSION: The present findings demonstrated not only the crucial role of the hexapeptide of SpsA, not only for the SpsA-pIgR interaction, but also for adherence and invasion of hpIgR-expressing cells.
Authors: D Daniely; M Portnoi; M Shagan; A Porgador; N Givon-Lavi; E Ling; R Dagan; Y Mizrachi Nebenzahl Journal: Clin Exp Immunol Date: 2006-05 Impact factor: 4.330
Authors: Rensheng Luo; Beth Mann; William S Lewis; Arthur Rowe; Richard Heath; Michael L Stewart; Agnes E Hamburger; Siva Sivakolundu; Eilyn R Lacy; Pamela J Bjorkman; Elaine Tuomanen; Richard W Kriwacki Journal: EMBO J Date: 2004-12-16 Impact factor: 11.598
Authors: Adriana T Moreno; Maria Leonor S Oliveira; Paulo L Ho; Cintia F M Vadesilho; Giovana M P Palma; Jorge M C Ferreira; Daniela M Ferreira; Silvia R Santos; Marina B Martinez; Eliane N Miyaji Journal: Clin Vaccine Immunol Date: 2012-02-15
Authors: Erika van der Maten; Bryan van den Broek; Marien I de Jonge; Kim J W Rensen; Marc J Eleveld; Aldert L Zomer; Amelieke J H Cremers; Gerben Ferwerda; Ronald de Groot; Jeroen D Langereis; Michiel van der Flier Journal: Infect Immun Date: 2018-03-22 Impact factor: 3.441
Authors: Lena Muchnik; Asad Adawi; Ariel Ohayon; Shahar Dotan; Itai Malka; Shalhevet Azriel; Marilou Shagan; Maxim Portnoi; Daniel Kafka; Hannie Nahmani; Angel Porgador; Jonathan M Gershoni; Johnatan M Gershoni; Donald A Morrison; Andrea Mitchell; Michael Tal; Ronald Ellis; Ron Dagan; Yaffa Mizrachi Nebenzahl Journal: PLoS One Date: 2013-04-08 Impact factor: 3.240
Authors: Stephen B Gordon; Nigel G Bruce; Jonathan Grigg; Patricia L Hibberd; Om P Kurmi; Kin-bong Hubert Lam; Kevin Mortimer; Kwaku Poku Asante; Kalpana Balakrishnan; John Balmes; Naor Bar-Zeev; Michael N Bates; Patrick N Breysse; Sonia Buist; Zhengming Chen; Deborah Havens; Darby Jack; Surinder Jindal; Haidong Kan; Sumi Mehta; Peter Moschovis; Luke Naeher; Archana Patel; Rogelio Perez-Padilla; Daniel Pope; Jamie Rylance; Sean Semple; William J Martin Journal: Lancet Respir Med Date: 2014-09-02 Impact factor: 30.700